Patent · US Active

Use of rosuvastatin lactols as medicaments

US9102656B2 · kind B2 · utility

6Cited by

2References

26Claims

0Family size

Assignee

RedX Pharma Limited · GB

Inventors

Derek Shane Lindsay · Marysville, US
Peter Jackson · Wigan, GB

Key dates

Filing date	Sep 17, 2013
Grant date	Aug 11, 2015
Priority date	—
Expiry date	Sep 17, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to the discovery of novel rosuvastatin analogs. More specifically, the invention relates to novel rosuvastatin analogs which have utility in treating conditions treatable by the inhibition of HMG-CoA reductase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.